Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
priority review
Biotech
FDA opens national priority fast track, offering 2-month reviews
The FDA has begun accepting applications for a fast-track pilot, giving medicines that align with U.S. priorities an accelerated route to market.
Nick Paul Taylor
Jul 23, 2025 6:35am
AbbVie's Roche-rivaling bispecific gets FDA priority review
Nov 21, 2022 9:45am
Sanofi gets FDA priority review for hemophilia A candidate
Aug 30, 2022 9:20am
FDA accepts CSL Behring’s gene therapy for speedy review
May 24, 2022 10:59am
